Australia markets closed

Shanghai Bio-heart Biological Technology Co., Ltd. (2185.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
2.220+0.120 (+5.71%)
As of 03:05PM HKT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
-
Operating expenses
Research development
111,743
111,743
157,830
214,228
245,743
-
Selling general and administrative
16,090
16,090
13,266
29,737
81,556
-
Total operating expenses
163,676
163,676
251,114
403,777
324,268
-
Operating income or loss
-163,676
-163,676
-251,114
-403,777
-324,268
-
Interest expense
578
578
959
685
56
-
Income before tax
-188,820
-188,820
-230,868
-409,825
-340,294
-
Income tax expense
0
0
0
0
0
-
Income from continuing operations
-188,820
-188,820
-230,868
-409,825
-340,294
-
Net income
-175,893
-175,893
-204,236
-361,449
-325,523
-
Net income available to common shareholders
-175,893
-175,893
-204,236
-361,449
-325,523
-
Basic EPS
-0.77
-
-0.84
-1.64
-1.37
-0.10
Diluted EPS
-0.77
-
-0.84
-1.64
-1.37
-0.10
Basic average shares
243,485
-
243,745
220,590
237,937
237,937
Diluted average shares
243,485
-
243,745
220,590
237,937
237,937